Long-term efficacy of repeated daily prefrontal transcranial magnetic stimulation (TMS) in treatmnt-resistant depression

Depression and Anxiety

Volumn 29, Issue 10, 2012, Pages 883-890

  Mantovani, Antonio ^a,b   Pavlicova, Martina ^a   Avery, David ^c   Nahas, Ziad ^d   McDonald, William M ^e   Wajdik, Chandra D ^c   Holtzheimer, Paul E ^f   George, Mark S ^g,h   Sackeim, Harold A ^a   Lisanby, Sarah H ⁱ  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b UNIVERSITY OF SIENA   (Italy)

^c UNIVERSITY OF WASHINGTON   (United States)

^d AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^g MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^h RALPH H JOHNSON VA MEDICAL CENTER   (United States)

ⁱ DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

depression; efficacy; follow up; transcranial magnetic stimulation; treatment resistant

Indexed keywords

AMFEBUTAMONE; LAMOTRIGINE; LITHIUM; LORAZEPAM; SERTRALINE; VENLAFAXINE; ZOLPIDEM;

ADULT; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN STUDY; OUTCOME ASSESSMENT; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PREFRONTAL CORTEX; PRIORITY JOURNAL; RELAPSE; REMISSION; SHAM PROCEDURE; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT RESISTANT DEPRESSION; TREATMENT RESPONSE;

DEPRESSIVE DISORDER, TREATMENT-RESISTANT; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PREFRONTAL CORTEX; PSYCHIATRIC STATUS RATING SCALES; RECURRENCE; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

EID: 84867100840     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.21967     Document Type: Article

References (30)

1. Holtzheimer PE III, Nemeroff CB,. Novel targets for antidepressant therapies. Curr Psychiatr Rep 2008; 10: 465-473.
2. Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006; 163: 1905-1917.
3. Kellner CH, Knapp RG, Petrides G, et al. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the consortium for research in electroconvulsive therapy (CORE). Arch Gen Psychiatry 2006; 63: 1337-1344.
4. Padberg F, George MS,. Repetitive transcranial magnetic stimulation of the prefrontal cortex in depression. Exp Neurol 2009; 219: 2-13.
5. Holtzheimer PE III, Russo J, Avery DH,. A meta-analysis of repetitive transcranial magnetic stimulation in the treatment of depression. Psychopharmacol Bull 2001; 35: 149-169.
6. Burt T, Lisanby SH, Sackeim HA,. Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis. Int J Neuropsychopharmacol 2002; 5: 73-103.
7. Martin JL, Barbanoj MJ, Schlaepfer TE, et al. Repetitive transcranial magnetic stimulation for the treatment of depression. Systematic review and meta-analysis. Br J Psychiatry 2003; 182: 480-491.
8. Couturier JL,. Efficacy of rapid-rate repetitive transcranial magnetic stimulation in the treatment of depression: a systematic review and meta-analysis. J Psychiatry Neurosci 2005; 30: 83-90.
9. Herrmann LL, Ebmeier KP,. Factors modifying the efficacy of transcranial magnetic stimulation in the treatment of depression: a review. J Clin Psychiatry 2006; 67: 1870-1876.
10. Schutter DJ,. Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis. Psychol Med 2009; 39: 65-75.
11. Slotema CW, Blom JD, Hoek HW, et al. Should we expand the toolbox of psychiatric treatment methods to include repetitive transcranial magnetic stimulation (rTMS)? A meta-analysis of the efficacy of rTMS in psychiatric disorders. J Clin Psychiatry 2010; 71: 873-884.
12. O'Reardon JP, Solvason HB, Janicak PG, et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry 2007; 62: 1208-1216.
13. Lisanby SH, Husain MM, Rosenquist PB, et al. Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial. Neuropsychopharmacology 2009; 34: 522-534.
14. George MS, Lisanby SH, Avery D, et al. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch Gen Psychiatry 2010; 67: 507-516.
15. Dannon PN, Dolberg OT, Schreiber S, et al. Three and six-month outcome following courses of either ECT or rTMS in a population of severely depressed individuals-preliminary report. Biol Psychiatry 2002; 51: 687-690.
16. O'Reardon JP, Blumner KH, Peshek AD, et al. Long-term maintenance therapy for major depressive disorder with rTMS. J Clin Psychiatry 2005; 66: 1524-1528.
17. Fitzgerald PB, Benitez J, de Castella AR, et al. Naturalistic study of the use of transcranial magnetic stimulation in the treatment of depressive relapse. Aust N Z J Psychiatry 2006; 40: 764-768.
18. Demirtas-Tatlidede A, Mechanic-Hamilton D, Press DZ, et al. An open-label, prospective study of repetitive transcranial magnetic stimulation (rTMS) in the long-term treatment of refractory depression: reproducibility and duration of the antidepressant effect in medication-free patients. J Clin Psychiatry 2008; 69: 930-934.
19. Cohen RB, Boggio PS, Fregni F,. Risk factors for relapse after remission with repetitive transcranial magnetic stimulation for the treatment of depression. Depress Anxiety 2009; 26: 682-688.
20. Janicak PG, Nahas Z, Lisanby SH, et al. Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study. Brain Stimul 2010; 3: 187-199.
21. Hamilton M,. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6: 278-296.
22. Sackeim HA,. The definition and meaning of treatment-resistant depression. J Clin Psychiatry 2001; 62 (Suppl 16): 10-17.
23. McDonald WM, Durkalski V, Ball E, et al. Improving the antidepressant efficacy of transcranial magnetic stimulation: maximizing the number of stimulations and treatment location in treatment resistant depression. Depress Anxiety 2011; 28: 973-980.
24. Prudic J, Haskett RF, Mulsant B, et al. Resistance to antidepressant medications and short-term clinical response to ECT. Am J Psychiatry 1996; 153: 985-992.
25. Hoencamp E, Haffmans J, Dijken WA, et al. Lithium augmentation of venlafaxine: an open-label trial. J Clin Psychopharmacol 2000; 20: 538-543.
26. Thase ME, Entsuah AR, Rudolph RL,. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. Br J Psychiatry 2001; 178: 234-241.
27. Langguth B, Landgrebe M, Zowe M, et al. Repetitive transcranial magnetic stimulation for maintenance treatment of depression: a case report. J Clin Psychiatry 2006; 67: 835-836.
28. O'Reardon JP, Blumner KH, Peshek AD, et al. Long-term maintenance therapy for major depressive disorder with rTMS. J Clin Psychiatry 2005; 66: 1524-1528.
29. Freitas C, Pearlman C, Pascual-Leone A,. Treatment of auditory verbal hallucinations with transcranial magnetic stimulation in a patient with psychotic major depression: One-year follow-up. Neurocase 2011; 25: 1-9.
30. Sackeim HA, Prudic J, Devanand DP, et al. The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J Clin Psychopharmacol 1990; 10: 96-104.